Epidermal growth factor (EGF) and its receptor (EGFR), which is most closely related to lung adenocarcinoma, were discovered by Stanley Cohen of Vanderbilt university in 1986[7]. This evidence concerns the gene EGFR and lung adenocarcinoma.